As with breast cancer, we performed additional immunohistochemical staining for estrogen receptor (ER) and progesterone receptor (PgR), and this revealed 10 out of 32 cases showed partial or complete loss of the ER expression without PgR expression. Here, PGR is linked to breast cancer.